CMS to in­crease re­im­burse­ment for new sick­le cell gene ther­a­pies

The Cen­ters for Medicare and Med­ic­aid Ser­vices (CMS) said Wednes­day that it will in­crease re­im­burse­ments for two new­ly ap­proved sick­le cell gene ther­a­pies that could …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER